SCHEMBL3553702

SCHEMBL3553702

COc1ccc(S(=O)(=O)n2c(C)c(OCCN(C)C)c3cc(Br)cc(Br)c32)c(OC)c1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 10/20 0.39
MAPK1 P28482 1/20 0.36
GFER P55789 1/20 0.36
PTPN1 P18031 1/20 0.35
UTS2R Q9UKP6 1/20 0.35
ALDH1A1 P00352 1/20 0.34
AVPR1B P47901 2/20 0.33
ESR1 P03372 1/20 0.33
KDR P35968 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
DYRK1A Q13627 1/20 0.33
OXTR P30559 1/20 0.33
NR1I2 O75469 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3564013 0.93 HTR6 (0.39) HTR6UTS2RESR1KDRHTR2A
SCHEMBL3559230 0.91 HTR6 (0.38) HTR6MAPK1GFERPTPN1UTS2R
SCHEMBL3566391 0.88 PTPN1 (0.40) HTR6MAPK1GFERPTPN1ALDH1A1
SCHEMBL3555613 0.86 HTR6 (0.48) HTR6MAPK1GFERALDH1A1AVPR1B
SCHEMBL3563867 0.85 CYP1A2 (0.38) MAPK1UTS2RALDH1A1
SCHEMBL3566115 0.84 HTR6 (0.38) HTR6ESR1KDRHTR2AHTR2C
SCHEMBL3559197 0.84 HTR7 (0.39) HTR6UTS2RALDH1A1
SCHEMBL3558722 0.83 HTR6 (0.39) HTR6MAPK1GFERALDH1A1ESR1
SCHEMBL3555819 0.82 HTR6 (0.54) HTR6ALDH1A1AVPR1BOXTR
SCHEMBL3563919 0.82 HTR6 (0.46) HTR6MAPK1GFERPTPN1UTS2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP claimed
US-7507835-B2 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LTD. (IN) 2009-03-24 US claimed
US-20060173193-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2006-08-03 US claimed
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed
US-7507835-B2 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LTD. (IN) 2009-03-24 US disclosed
US-20060173193-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2006-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT HTR6 56/4885MAPK1 2581/4885GFER 1772/4885
US-20060173193-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT HTR6 56/4885MAPK1 2581/4885GFER 1772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.